A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.

Saved in:
Bibliographic Details
Title: A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.
Authors: Pinto-Marín Á; Medical Oncology Service, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain. alvaro.pinto@salud.madrid.org., Trilla-Fuertes L; Molecular Oncology Lab, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain., Miranda Poma J; Medical Oncology Service, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain., Vasudev NS; Leeds Institute of Medical Research at St James's, University of Leeds, St. James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK., García-Fernández E; Department of Pathology, University Hospital La Paz, IDIPAZ, UAM, Madrid, Spain., López-Vacas R; Molecular Oncology Lab, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain., Miranda N; Urology Service, Hospital Universitario 12 de Octubre, Madrid, Spain., Wilson M; Leeds Institute of Medical Research at St James's, University of Leeds, St. James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK., López-Camacho E; Biomedica Molecular Medicine SL, Madrid, Spain.; Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Ctra. Pozuelo-Majadahonda Km 1,800, Madrid, Pozuelo de Alarcón, 28223, Spain., Pertejo A; Medical Oncology Service, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain., Dittmann A; Proteomics Group, Functional Genomics Center Zurich, Zurich, Switzerland., Kunz L; Proteomics Group, Functional Genomics Center Zurich, Zurich, Switzerland., Brown J; Leeds Institute of Medical Research at St James's, University of Leeds, St. James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK., Pedroche-Just Y; IdiPAZ Biobank, La Paz University Hospital-IdiPAZ, Madrid, Spain., Zapater-Moros A; Biomedica Molecular Medicine SL, Madrid, Spain., de Velasco G; Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain., Castellano D; Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain., González-Peramato P; Department of Pathology, University Hospital La Paz, IDIPAZ, UAM, Madrid, Spain., Espinosa E; Medical Oncology Service, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain.; Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain., Banks RE; Leeds Institute of Medical Research at St James's, University of Leeds, St. James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK., Fresno Vara JÁ; Molecular Oncology Lab, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain.; Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain., Gámez-Pozo A; Molecular Oncology Lab, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain. angelo.gamez@salud.madrid.org.; Biomedica Molecular Medicine SL, Madrid, Spain. angelo.gamez@salud.madrid.org.
Source: British journal of cancer [Br J Cancer] 2025 Aug; Vol. 133 (2), pp. 155-167. Date of Electronic Publication: 2025 May 07.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-025-03008-2